What are the benefits and risks of drugs acting on the immune

What are the benefits and risks of drugs acting on the immune system to treat relapsing-remitting multiple sclerosis ?

Listen now

Description

There are more than 60 Cochrane Reviews relevant to multiple sclerosis and, one of these, a network meta-analysis of immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis, was updated in January 2024. We asked the lead author, Francesco Nonino from the Institute of Neurological Science in Bologna, Italy, to tell us more about the condition and the latest evidence in this podcast.

More Episodes

See all »

Cochrane Library Podcasts

Published 04/18/24

What are the benefits and risks of health literacy interventions for migrants?

Patient understanding can be key to the successful use of many of the interventions for which there are Cochrane Reviews and, in November 2023, we published a review that might help with this. Here are two of the authors, Angela Aldin from Cochrane Haematology and Annika Baumeister from the...

Published 04/18/24

Can psychosocial interventions reduce antipsychotic medication in care home residents?

Alongside its many reviews of possible treatments for dementia, the Cochrane Dementia and Cognitive Improvement Group produced reviews relevant to other aspects of the care of people with dementia. In this podcast, Tanja Richter talks with Julia Lühnen (Charité – Universitätsmedizin Berlin,...

Published 04/11/24